DE/EN
  • Deutsch
  • English
  • About us
    • His­tory
    • Who we are
    • Man­age­ment
    • Found­a­tion
    • Super­vis­ory Board
    • Sci­entific Advis­ory Board
    • Sci­entific Advisors
  • Back­ground
  • Research
    • Pro­jects
    • Pub­lic­a­tions
  • Ser­vices
    • Gen­ome Editing
    • Human iPS cells
    • ELISA-based meas­ure­ments (GLP)
    • Reg­u­lat­ory services
  • Co-Oper­­a­­tions
  • News
  • Jobs
  • Con­tact
REPROGRAM - REFINE - REGENERATE REPROGRAM - REFINE - REGENERATE REPROGRAM - REFINE - REGENERATE REPROGRAM - REFINE - REGENERATE
  • About us
    • His­tory
    • Who we are
    • Man­age­ment
    • Found­a­tion
    • Super­vis­ory Board
    • Sci­entific Advis­ory Board
    • Sci­entific Advisors
  • Back­ground
  • Research
    • Pro­jects
    • Pub­lic­a­tions
  • Ser­vices
    • Gen­ome Editing
    • Human iPS cells
    • ELISA-based meas­ure­ments (GLP)
    • Reg­u­lat­ory services
  • Co-Oper­­a­­tions
  • News
  • Jobs
  • Con­tact

Archives

Monthly Archive for: "December, 2019"
Home » Archives for December 2019
 sTREM2, a poten­tial bio­marker in AD
0
By
In Publications
Posted 28. December 2019

sTREM2, a poten­tial bio­marker in AD

sTREM2 correlates with microglia activation, and higher CSF sTREM2 levels can be linked to reduced cognitive decline and slower rates of Plaque accumulation in AD patients.


READ MORE
  • +49 89 356 475 400
  • info@isarbioscience.de
NAVIGATION
  • About us
  • Back­ground
  • Research
  • Co-Oper­­a­­tions
SERVICE
  • News
  • Jobs
  • Con­tact
© 2020 ISAR Bioscience. All rights reserved.
  • Pri­vacy Policy
  • Legal Inform­a­tion
  • DeutschDeutsch